CompletedPhase 2NCT00003396
Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Studying Acute basophilic leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Maryland, Baltimore
- Principal Investigator
- Barry R. Meisenberg, MDUniversity of Maryland Greenebaum Cancer Center
- Intervention
- anti-thymocyte globulin(biological)
- Enrollment
- 42 enrolled
- Eligibility
- 120 years · All sexes
- Timeline
- 1998 – 2002
Study locations (1)
- Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, United States
Collaborators
University of Maryland Greenebaum Cancer Center
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00003396 on ClinicalTrials.govOther trials for Acute basophilic leukemia
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGPHASE2NCT01627041Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid LeukemiaNational Cancer Institute (NCI)
- ACTIVE NOT RECRUITINGNCT00898456Multidrug Resistance Genes in Patients With Acute Myeloid LeukemiaAlliance for Clinical Trials in Oncology